Deutsche Bank set a €17.00 ($20.24) price target on ING Group (AMS:INGA) in a research report report published on Thursday. The brokerage currently has a buy rating on the stock.
A number of other equities analysts have also recently commented on INGA. JPMorgan Chase set a €17.40 ($20.71) target price on ING Group and gave the stock a buy rating in a report on Wednesday. Royal Bank of Canada set a €16.50 ($19.64) price target on ING Group and gave the company a buy rating in a report on Wednesday. Credit Suisse Group set a €13.50 ($16.07) price target on ING Group and gave the company a sell rating in a report on Wednesday. Goldman Sachs set a €17.75 ($21.13) price target on ING Group and gave the company a buy rating in a report on Thursday. Finally, UBS set a €18.30 ($21.79) price target on ING Group and gave the company a buy rating in a report on Friday, January 19th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and eleven have given a buy rating to the company’s stock. The stock currently has an average rating of Buy and an average target price of €16.60 ($19.76).
Best Gold Stocks To Own Right Now: ArQule Inc.(ARQL)
- [By Ethan Ryder]
Get a free copy of the Zacks research report on ArQule (ARQL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
ArQule (NASDAQ:ARQL)‘s stock had its “buy” rating restated by equities researchers at Needham & Company LLC in a research report issued to clients and investors on Tuesday, Marketbeat Ratings reports. They currently have a $6.00 price target on the biotechnology company’s stock, up from their prior price target of $5.00. Needham & Company LLC’s price target suggests a potential upside of 134.38% from the company’s previous close.
- [By Stephan Byrd]
ArQule, Inc. (NASDAQ:ARQL) Director Ronald M. Lindsay acquired 23,900 shares of the company’s stock in a transaction on Thursday, May 10th. The stock was acquired at an average price of $2.67 per share, for a total transaction of $63,813.00. Following the purchase, the director now directly owns 43,900 shares of the company’s stock, valued at $117,213. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Best Gold Stocks To Own Right Now: ENGlobal Corporation(ENG)
- [By Max Byerly]
ENGlobal (NASDAQ:ENG) will be announcing its earnings results before the market opens on Wednesday, May 9th.
ENGlobal (NASDAQ:ENG) last released its quarterly earnings data on Thursday, March 15th. The construction company reported ($0.08) earnings per share for the quarter. ENGlobal had a negative net margin of 29.16% and a negative return on equity of 17.18%. The firm had revenue of $14.43 million during the quarter.
Best Gold Stocks To Own Right Now: Provident Financial Services, Inc(PFS)
- [By Logan Wallace]
Here are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:
Get Provident Financial Services alerts:
Head-To-Head Review: Provident Financial (PROV) versus Provident Financial Services (PFS) (americanbankingnews.com) Head-To-Head Contrast: Territorial Bancorp (TBNK) & Provident Financial Services (PFS) (americanbankingnews.com) Q3 2018 EPS Estimates for Provident Financial Services, Inc. Decreased by Piper Jaffray (PFS) (americanbankingnews.com) Provident Financial Services, Inc. (PFS) Given Average Rating of “Hold” by Brokerages (americanbankingnews.com)
A number of research analysts have issued reports on PFS shares. Sandler O’Neill raised shares of Provident Financial Services from a “hold” rating to a “buy” rating and set a $29.00 price objective on the stock in a research report on Friday, January 26th. ValuEngine raised shares of Provident Financial Services from a “hold” rating to a “buy” rating in a research report on Wednesday, March 7th. Zacks Investment Research downgraded shares of Provident Financial Services from a “buy” rating to a “hold” rating in a research report on Wednesday, February 21st. Boenning Scattergood reissued a “hold” rating on shares of Provident Financial Services in a research report on Monday, January 29th. Finally, Piper Jaffray reissued a “hold” rating and set a $28.00 price objective on shares of Provident Financial Services in a research report on Tuesday, January 9th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. Provident Financial Services currently has a consensus rating of “Hold” and an average price target of $28.42.
Best Gold Stocks To Own Right Now: Aurora Cannabis Inc. (ACBFF)
- [By Sean Williams]
Not too far behind Canopy Growth is Aurora Cannabis (NASDAQOTH:ACBFF), which has grown every which way over the past year, and is on track to deliver more than 430,000 kilograms in fully funded capacity.
- [By Keith Speights]
Even Canadian marijuana stocks that don’t have significant U.S. ties received a boost. The share prices of the two largest Canadian marijuana growers by market cap, Canopy Growth (NASDAQOTH:TWMJF) and Aurora Cannabis (NASDAQOTH:ACBFF), rose 7% and 8%, respectively.
- [By Sean Williams]
It just so happens that one of Canada’s top two players in the cannabis industry, Aurora Cannabis (NASDAQOTH:ACBFF), reported its third-quarter operating results on May 8 and updated investors on what to expect going forward. Given its importance to the domestic Canadian pot industry — the company expects to generate 430,000 kilograms of cannabis a year at full capacity — it pays to keep tabs on Aurora’s growth and how its projects are progressing. That said, here are the 10 things you should know about Aurora Cannabis’ Q3 report.
- [By ]
What are the risks? First off, the Cannabis market in Canada is already competitive, and it’s the fifth largest company behind the likes of Canopy (OTCPK:TWMJF), Aurora (OTCQX:ACBFF), Aphria (OTCQB:APHQF), Medreleaf (OTCPK:MEDFF), and Cronos (OTC:CRON). What’s more, there are approximately 228 million fully diluted shares, selling at $3.16/share ($4.04/share $CAD), and the company generated $CAD4.09mm in 2017 revenues. That’s quite a premium, and Hydropothecary Corp. trades expensively at a 225x sales multiple. Caveat emptor.
- [By ]
As we discussed the topic extensively in “The Complete Cannabis Guide #1: Production Cost”, Cronos reported its production cost similar to Aphria which includes overhead allocation and amortization. Other companies such as Canopy (OTCPK:TWMJF) and Aurora (OTCQX:ACBFF) report cash production cost which excludes non-cash costs such as amortization. Production cost was $2.18 per gram during the quarter, a very high number among the large peers. For reference Canopy reported production costs of $1.03 and Aphria reported $1.45 for its most recent quarter. The higher production cost was due to Cronos operating mostly indoor facilities compared to greenhouses. The greenhouse at Peace Naturals is very small with just 1,500 kg entering production during the second quarter, which should help bring down the production cost. Overall, Cronos is not and does not expect to become a low-cost producer, which is a concern especially given that the company has had to sell to the wholesale market for lower prices.